CDY 1.43% 7.1¢ cellmid limited

Regarding eye lash etc, diversifying in to generic products...

  1. 118 Posts.
    lightbulb Created with Sketch. 7
    Regarding eye lash etc, diversifying in to generic products before achieving any sort of market penetration with the core products(they have a differentiating factor) is a bad move in my book.
 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.